Brought to you by 
Nora Therapeutics announces $25mm Series A round; later adds on through new investor
17 Apr 2014
Executive Summary
Nora Therapeutics, a start-up developing treatments and diagnostics for women's reproductive health, has announceed a $25mm Series A round. Backers included Burrill & Co., which led, Prospect Venture Partners, and Vivo Ventures.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nora Therapeutics announces $25mm Series A round; later adds on through new investor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice